In this episode of the Oncology Insights Podcast, Dr. Petros Grivas welcomes Dr. Christina Rodriguez to discuss her journey ...
GVHD can range from mild and temporary to life-threatening and chronic — but the deadly, debilitating cases are rare now. As ...
Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...
A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...
On Oct. 9, 2025, Fred Hutch Cancer Center employees with decades of service were honored at a luncheon celebrating their ...
New Fred Hutch Cancer Center viral immunologist Dr. Paul Thomas is working to turn the "incredible potential" of the immune ...
As chief medical officer, Tom Purcell, MD, MBA, is overseeing an organization-wide initiative to improve the delivery of care ...
A cancer diagnosis always brings challenges and uncertainty. But for those diagnosed with so-called “rare” cancers — traditionally described as diseases that affect 40,000 or fewer Americans every ...
Stuart and Molly Sloan add to their 2022 transformational gift to boost their impact on research and care SEATTLE – July 22, 2025 – A Fred Hutch Cancer Center outpatient complex serving more than ...
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...
The Food Biomarkers Study (FBS) is a research project to help scientists learn how markers of consuming certain protein foods appear in blood and urine. The study involves three, 9-day study food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback